Ryan, Michael
Donato, Bonnie M. K.
Irish, William
Gasteyger, Christoph
L’Italien, Gilbert
Laurence, Jeffrey
Funding for this research was provided by:
Alexion Pharmaceuticals Inc
Article History
First Online: 12 December 2019
Compliance with Ethical Standards
:
: This study was funded by Alexion Pharmaceuticals, Inc. (study funder). Study design was undertaken by Bonnie M.K. Donato and Gilbert L’Italien (former employees of study funder). Study conduct was overseen by Michael Ryan and William Irish (contracted by study funder). Data analysis and interpretation was undertaken by Christoph Gasteyger (employee of study funder) and Jeffrey Laurence (a consultant to the study funder). The first draft of the manuscript was developed by the medical writer (contracted by the study funder) under guidance from the authors.
: Michael Ryan is an employee of CTI, a paid consultant of Alexion. Bonnie M.K. Donato is an employee of Boehringer-Ingelheim Pharmaceutical Inc. and was an employee of Alexion Pharmaceuticals, Inc. at the time of the study. William Irish has no disclosures to declare. Christoph Gasteyger is an employee of Alexion Pharma GmbH. Gilbert L’Italien is a former employee of Alexion Pharmaceuticals, Inc. Jeffrey Laurence is a consultant to Alexion.
: This study has been approved by the appropriate institutional and/or national research ethics committee and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.